Clinical Trials Logo
  1. Home
  2. Pneumococcal Vaccines
  3. NCT01537185

Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults

Pneumococcal Vaccines Clinical Trial

Official title:
A Phase 1 Randomized, Double-Blind, Dose-Escalation Study to Assess the Safety, Tolerability and Immunogenicity of Inactivated Streptococcus Pneumoniae Whole Cell Vaccine Formulated With Alum (SPWCV+Alum) in Healthy Adults

Clinical Trial Summary

The purpose of this study is to determine if a Streptococcus pneumoniae Whole Cell Vaccine (SPWCV) given with alum is safe and well tolerated by healthy adults.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01537185
Study type Interventional
Source PATH
Contact
Status Completed
Phase Phase 1
Start date February 2012
Completion date April 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01953510 - Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam Phase 2/Phase 3
Completed NCT05540028 - Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine Phase 1
Recruiting NCT05298800 - Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 Phase 4
Active, not recruiting NCT06077656 - Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine Phase 2
Active, not recruiting NCT06151288 - Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults Phase 1/Phase 2
Recruiting NCT06000397 - Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age N/A
Completed NCT00574548 - Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS Phase 3
Not yet recruiting NCT06271681 - Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans Phase 4
Active, not recruiting NCT05844423 - Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants Phase 2
Completed NCT00824655 - Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Phase 3
Completed NCT01646398 - A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older Phase 3
Completed NCT00464945 - Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants Phase 3
Completed NCT03893448 - Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) Phase 3
Completed NCT05297578 - Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults Phase 2
Completed NCT01964716 - 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. Phase 3
Completed NCT05266456 - Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults Phase 1/Phase 2
Recruiting NCT00999739 - Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults Phase 3
Not yet recruiting NCT05721456 - Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil. Phase 3
Active, not recruiting NCT02012309 - Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses N/A
Completed NCT01392378 - Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® Phase 4